MENU
PIPELINE.
Our pipeline strategy will support the company's social impact mission by producing revenue from identified and demonstrated biosimilar blockbuster drugs. This revenue will support our dedication to raising awareness of plant-made pharmaceuticals for underserved areas, markets, and patients and our national security and rare disease missions.
Phylloceuticals has created an innovative three-pronged pipeline approach.
CMO/ CDMO SERVICES
-
Enable the age of AI-discovery (pre-clinical partnership)
-
Dramatically improve speed to production
-
Reduce manufacturing costs
-
IND-enabling
-
Clinical and Commercial
-
GOOD
SAMARITAN
Provide for often ignored diseases:
-
National Security
-
Military Responsiveness
-
Rare Disease
-
Difficult to make in CHO cells
Proven blockbuster drug. Early, lucrative revenue opportunity.
BLOCKBUSTER ACCELERATOR
WHAT’S NEXT STARTS HERE.
Get in touch at info@phylloceuticals.com